Brian O'callaghan - Net Worth and Insider Trading

Brian O'callaghan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian O'callaghan owns 3 companies in total, including Bolt Biotherapeutics Inc (BOLT) , Indaptus Therapeutics Inc (INDP) , and ObsEva SA (OBSEF) .

Click here to see the complete history of Brian O'callaghan’s form 4 insider trades.

Insider Ownership Summary of Brian O'callaghan

Ticker	Comapny	Transaction Date	Type of Owner
BOLT	Bolt Biotherapeutics Inc	2022-03-24	director
INDP	Indaptus Therapeutics Inc	2021-08-03	director
OBSEF	ObsEva SA	2023-01-01	director & Chief Executive Officer

Brian O'callaghan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian O'callaghan Ownership Network

Ownership Network List of Brian O'callaghan

No Data

Ownership Network Relation of Brian O'callaghan

Brian O'callaghan Owned Company Details

What does Bolt Biotherapeutics Inc do?

Who are the key executives at Bolt Biotherapeutics Inc?

Brian O'callaghan is the director of Bolt Biotherapeutics Inc. Other key executives at Bolt Biotherapeutics Inc include Chief Financial Officer William P. Quinn , 10 percent owner Vivo Capital Fund Viii, L.p. , and 10 percent owner Novo Holdings A/s .

Bolt Biotherapeutics Inc (BOLT) Insider Trades Summary

Over the past 18 months, Brian O'callaghan made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bolt Biotherapeutics Inc Insider Transactions

No Available Data

What does Indaptus Therapeutics Inc do?

Who are the key executives at Indaptus Therapeutics Inc?

Brian O'callaghan is the director of Indaptus Therapeutics Inc. Other key executives at Indaptus Therapeutics Inc include 10 percent owner Glen R. Anderson , Chief Medical Officer Roger J. Waltzman , and Chief Medical Officer Boyan Vesselinov Litchev .

Indaptus Therapeutics Inc (INDP) Insider Trades Summary

Over the past 18 months, Brian O'callaghan made no insider transaction in Indaptus Therapeutics Inc (INDP). Other recent insider transactions involving Indaptus Therapeutics Inc (INDP) include a net purchase of 103,352 shares made by Glen R. Anderson , a net purchase of 10,000 shares made by Jeffrey A Meckler , and a net purchase of 1,150 shares made by Boyan Vesselinov Litchev .

In summary, during the past 3 months, insiders sold 0 shares of Indaptus Therapeutics Inc (INDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Indaptus Therapeutics Inc (INDP) were sold and 114,502 shares were bought by its insiders, resulting in a net purchase of 114,502 shares.

Indaptus Therapeutics Inc (INDP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Indaptus Therapeutics Inc Insider Transactions

No Available Data

What does ObsEva SA do?

Who are the key executives at ObsEva SA?

Brian O'callaghan is the director & Chief Executive Officer of ObsEva SA. Other key executives at ObsEva SA include and Chief Financial Officer William Michael Brown .

ObsEva SA (OBSEF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ObsEva SA (OBSEF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ObsEva SA (OBSEF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ObsEva SA (OBSEF)'s detailed insider trading history can be found in Insider Trading Tracker table.

ObsEva SA Insider Transactions

No Available Data

Brian O'callaghan Mailing Address

Above is the net worth, insider trading, and ownership report for Brian O'callaghan. You might contact Brian O'callaghan via mailing address: 550 Hills Drive, 3rd Floor, Bedminster Nj 07921.

Discussions on Brian O'callaghan

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.